News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16 Results
Type
Article (3)
Press Release (13)
Section
Business (5)
News (5)
Tag
Cancer (1)
CAR-T (1)
Cell therapy (1)
Collaboration (1)
Events (2)
Gene therapy (4)
Manufacturing (2)
People (7)
Pipeline (1)
Date
Last 365 days (3)
2025 (3)
2024 (3)
2023 (4)
2022 (1)
2021 (3)
2010 (1)
Location
Asia (2)
Australia (2)
Europe (13)
New York (5)
United States (5)
16 Results for "virocell".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ViroCell Biologics and AvenCell Therapeutics Announce Retroviral Vector Manufacturing Collaboration to Accelerate Development of Novel Allogeneic CAR-T Therapies for Blood Cancers
July 29, 2025
·
4 min read
Press Releases
ViroCell Biologics Appoints Viral Vector Expert as Special Advisor
March 27, 2025
·
2 min read
Pharm Country
ViroCell to present at 2024 Cell & Gene Meeting on the Med
ViroCell Biologics announces that John W. Hadden II, Chief Executive Officer, will be presenting at the annual Cell & Gene Meeting on the Med to be held April 9-11 in Rome, Italy.
April 8, 2024
·
3 min read
Press Releases
ViroCell Manufactured a GMP Lentiviral Vector for UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer
April 17, 2025
·
4 min read
Press Releases
ViroCell Biologics Expands U.S. Business Development Team With Two New Appointments
December 16, 2024
·
3 min read
Business
ViroCell Appoints Brian Collins as CFO
ViroCell Biologics, a specialist Contract Development and Manufacturing Organisation in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer.
July 26, 2023
·
3 min read
Press Releases
ViroCell Biologics to Host Panel Event at 2024 Cell & Gene Meeting on the Mesa
October 7, 2024
·
3 min read
Pharm Country
ViroCell Expands Business Development Team to Support Next Phase of Growth
ViroCell Biologics, a specialist contract development and manufacturing organisation in cell and gene therapy clinical trials, announces the appointment of Traci Kyes as Vice President of Business Development and Makis Sigalas as Senior Business Development Director.
October 4, 2023
·
5 min read
Pharm Country
ViroCell Signs Manufacturing Services Agreement with UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer
ViroCell Biologics announces a new partnership with University College London to advance Professor Persis Amrolia’s innovative chimeric antigen receptor T-cell therapy for relapsed paediatric acute lymphoblastic leukaemia.
December 12, 2023
·
4 min read
Pharm Country
ViroCell and Great Ormond Street Hospital Poised to Unlock Clinical Trial ‘Backlog’ Following MHRA Manufacturing Approval
ViroCell Biologics announces that the Company is now able to manufacture and globally export viral vectors from Great Ormond Street Hospital’s state-of-the-art manufacturing facility, the Zayed Centre for Research, for use in clinical trials.
November 1, 2023
·
5 min read
1 of 2
Next
